Truist Securities Maintains Buy on Ovintiv, Raises Price Target to $77

Benzinga Newsdesk www.benzinga.com Positive 75.9%

Neg 0% Neu 0% Pos 75.9%

Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $73 to $77.